Rebecca Groynom

Publications

Onwukwe, C., Maisha, N., Holland, M., Goss-Varley, M., Groynom, R., Hickman, R., Uppal, N., Shoffstall, A., Justin Gooding, J., & Lavik, E. B. (2018). Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma.. Bioconjugate chemistry, 29 (7), 2436-2447.
Lashof-Sullivan, M., Holland, M., Groynom, R., Campbell, D., Shoffstall, A., & Lavik, E. B. (2016). Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 <sup>°</sup>C.. ACS biomaterials science & engineering, 2 (3), 385-392.
Lashof-Sullivan, M., Holland, M., Groynom, R., Campbell, D., Shoffstall, A., & Lavik, E. B. (2016). Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C. ACS Biomaterials Science & Engineering [23739878], 2 (3), 385-392.
Shoffstall, A., Atkins, K., Groynom, R., Goss-Varley, M., Everhart, L., Lashof-Sullivan, M., Martyn-Dow, B., Butler, R., Justin Gooding, J., & Lavik, E. B. (2012). Intravenous hemostatic nanoparticles increase survival following blunt trauma injury.. Biomacromolecules, 13 (11), 3850-7.